-
公开(公告)号：US12091395B2
公开(公告)日：2024-09-17
申请号：US18501481
申请日：2023-11-03
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14
CPC classification number: C07D307/94 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.
wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号：US11834427B2
公开(公告)日：2023-12-05
申请号：US18046270
申请日：2022-10-13
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/14 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D413/10
CPC classification number: C07D307/94 , A61K31/343 , A61K31/4155 , A61K31/4245 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.
wherein the symbols in the formula are defined below:
R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group;
A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号：US20190092741A1
公开(公告)日：2019-03-28
申请号：US16088696
申请日：2017-03-29
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D413/14 , C07D413/10 , C07D405/10 , C07D407/12
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
-
公开(公告)号：US10654821B2
公开(公告)日：2020-05-19
申请号：US16561459
申请日：2019-09-05
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/10 , C07D413/14 , C07D413/10 , C07D407/12
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
-
公开(公告)号：US20200002302A1
公开(公告)日：2020-01-02
申请号：US16561459
申请日：2019-09-05
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/10 , C07D407/12 , C07D413/10 , C07D413/14
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
-
Patent Agency Ranking
公开(公告)号：US11981686B2
公开(公告)日：2024-05-14
申请号：US17425520
申请日：2020-01-23
Applicant: DAIICHI SANKYO COMPANY, LIMITED
Inventor： Junya Kawai , Osamu Iwamoto , Yuma Umezaki , Katsuyoshi Nakajima , Hiroyuki Tsuruoka , Keiji Saito , Nobuya Kurikawa , Natsumi Nishihama , Shinji Tanaka , Momoko Ogitani , Tomohiro Honda , Wataru Saitoh , Tsuyoshi Soneda , Nobuyuki Ohkawa
IPC: C07D513/18 , C07D513/04
CPC classification number: C07D513/18 , C07D513/04
Abstract: An object of the present invention is to provide a compound that has a specific chemical structure having an activation effect on SIRT6 and is useful as an active component for preventing and treating inflammatory diseases, and the present invention relates to a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof,
where each symbol in Formula (1) has the same definition as that described in the specification.-
公开(公告)号：US20210292292A1
公开(公告)日：2021-09-23
申请号：US17212373
申请日：2021-03-25
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/04 , C07D413/04 , A61K31/4155 , A61K31/4245 , A61K31/343 , C07D405/10 , C07D407/12 , C07D413/10 , C07D413/14
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号：US10975052B2
公开(公告)日：2021-04-13
申请号：US16844621
申请日：2020-04-09
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14 , A61K31/343 , A61K31/4155 , A61K31/4245
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号：US20230136988A1
公开(公告)日：2023-05-04
申请号：US18046270
申请日：2022-10-13
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/04 , C07D413/04 , A61K31/4155 , A61K31/4245 , A61K31/343 , C07D405/10 , C07D407/12 , C07D413/10 , C07D413/14
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.-
公开(公告)号：US11472784B2
公开(公告)日：2022-10-18
申请号：US17212373
申请日：2021-03-25
Applicant: Daiichi Sankyo Company, Limited
Inventor： Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
IPC: C07D307/94 , C07D405/04 , C07D405/10 , C07D407/12 , C07D413/04 , C07D413/10 , C07D413/14 , A61K31/343 , A61K31/4155 , A61K31/4245
Abstract: An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.017 seconds)
